HNC: pre-CRT lymphocyte-to-monocyte ratio predicts survival

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • The pretreatment lymphocyte-to-monocyte ratio (LMR) is an independent prognostic factor for patients with head and neck cancer (HNC) undergoing chemoradiotherapy (CRT).

Key results

  • A high LMR was associated with laryngeal cancer (P=.049), T1-T2 stage disease (P=.038), and cli...